Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
A Small Molecule Smac Mimic Potentiates TRAIL- and TNF-Mediated Cell Death
Lin Li,1*Ranny Mathew Thomas,1*Hidetaka Suzuki,1*Jef K. De Brabander,1Xiaodong Wang,1,2Patrick G. Harran1
We describe the synthesis and properties of a small moleculemimic of Smac, a pro-apoptotic protein that functions by relievinginhibitor-of-apoptosis protein (IAP)mediated suppressionof caspase activity. The compound binds to X chromosomeencoded IAP (XIAP), cellular IAP 1 (cIAP-1), and cellular IAP2 (cIAP-2) and synergizes with both tumor necrosis factor (TNF)and TNF-related apoptosis-inducing ligand (TRAIL) to potentlyinduce caspase activation and apoptosis in human cancer cells.The molecule has allowed a temporal, unbiased evaluation ofthe roles that IAP proteins play during signaling from TRAILand TNF receptors. The compound is also a lead structure forthe development of IAP antagonists potentially useful as therapyfor cancer and inflammatory diseases.
1 Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 753909038, USA. 2 Howard Hughes Medical Institute, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 753909038, USA.
* These authors contributed equally to the work.
To whom correspondence should be addressed. E-mail: pharra{at}biochem.swmed.edu (P.G.H.), xwang{at}biochem.swmed.edu (X.W.), jdebra{at}biochem.swmed.edu (J.K.D.)
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Catherine Denicourt and Steven F. Dowdy (3 September 2004) Science305 (5689), 1411.
[DOI: 10.1126/science.1102974] |Summary »|Full Text »|PDF »
REPORTS
Loren D. Walensky, Andrew L. Kung, Iris Escher, Thomas J. Malia, Scott Barbuto, Renee D. Wright, Gerhard Wagner, Gregory L. Verdine, and Stanley J. Korsmeyer (3 September 2004) Science305 (5689), 1466.
[DOI: 10.1126/science.1099191] |Abstract »|Full Text »|PDF »|Supporting Online Material »
S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease.
A. H. K. Tsang, Y.-I. Lee, H. S. Ko, J. M. Savitt, O. Pletnikova, J. C. Troncoso, V. L. Dawson, T. M. Dawson, and K. K. K. Chung (2009)
PNAS
106, 4900-4905
|Abstract »|Full Text »|PDF »
Small Molecule XIAP Inhibitors Enhance TRAIL-Induced Apoptosis and Antitumor Activity in Preclinical Models of Pancreatic Carcinoma.
M. Vogler, H. Walczak, D. Stadel, T. L. Haas, F. Genze, M. Jovanovic, U. Bhanot, C. Hasel, P. Moller, J. E. Gschwend, et al. (2009)
Cancer Res.
69, 2425-2434
|Abstract »|Full Text »|PDF »
Challenge and promise: roles for Livin in progression and therapy of cancer.
L. Wang, Q. Zhang, B. Liu, M. Han, and B. Shan (2008)
Mol. Cancer Ther.
7, 3661-3669
|Abstract »|Full Text »|PDF »
Molecularly Targeted Radiosensitization of Human Prostate Cancer by Modulating Inhibitor of Apoptosis.
Y. Dai, M. Liu, W. Tang, J. DeSano, E. Burstein, M. Davis, K. Pienta, T. Lawrence, and L. Xu (2008)
Clin. Cancer Res.
14, 7701-7710
|Abstract »|Full Text »|PDF »
SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP.
J. Lu, L. Bai, H. Sun, Z. Nikolovska-Coleska, D. McEachern, S. Qiu, R. S. Miller, H. Yi, S. Shangary, Y. Sun, et al. (2008)
Cancer Res.
68, 9384-9393
|Abstract »|Full Text »|PDF »
Diverse functions within the IAP family.
J. M. Rumble and C. S. Duckett (2008)
J. Cell Sci.
121, 3505-3507
|Full Text »|PDF »
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNF{alpha}.
J. E. Vince, D. Chau, B. Callus, W. W.-L. Wong, C. J. Hawkins, P. Schneider, M. McKinlay, C. A. Benetatos, S. M. Condon, S. K. Chunduru, et al. (2008)
J. Cell Biol.
182, 171-184
|Abstract »|Full Text »|PDF »
Differential Roles of JNK in ConA/GalN and ConA-Induced Liver Injury in Mice.
H.-M. Ni, X. Chen, W.-X. Ding, M. Schuchmann, and X.-M. Yin (2008)
Am. J. Pathol.
173, 962-972
|Abstract »|Full Text »|PDF »
Regulation of apoptosis by XIAP ubiquitin-ligase activity.
A. J. Schile, M. Garcia-Fernandez, and H. Steller (2008)
Genes & Dev.
22, 2256-2266
|Abstract »|Full Text »|PDF »
Essential Cytoplasmic Translocation of a Cytokine Receptor-Assembled Signaling Complex.
A. Matsuzawa, P.-H. Tseng, S. Vallabhapurapu, J.-L. Luo, W. Zhang, H. Wang, D. A. A. Vignali, E. Gallagher, and M. Karin (2008)
Science
321, 663-668
|Abstract »|Full Text »|PDF »
A New Small Molecule Inhibitor of Estrogen Receptor {alpha} Binding to Estrogen Response Elements Blocks Estrogen-dependent Growth of Cancer Cells.
C. Mao, N. M. Patterson, M. T. Cherian, I. O. Aninye, C. Zhang, J. B. Montoya, J. Cheng, K. S. Putt, P. J. Hergenrother, E. M. Wilson, et al. (2008)
J. Biol. Chem.
283, 12819-12830
|Abstract »|Full Text »|PDF »
Small Molecules Destabilize cIAP1 by Activating Auto-ubiquitylation.
K. Sekine, K. Takubo, R. Kikuchi, M. Nishimoto, M. Kitagawa, F. Abe, K. Nishikawa, T. Tsuruo, and M. Naito (2008)
J. Biol. Chem.
283, 8961-8968
|Abstract »|Full Text »|PDF »
Anti-Apoptosis Mechanisms in Malignant Gliomas.
D. S. Ziegler, A. L. Kung, and M. W. Kieran (2008)
J. Clin. Oncol.
26, 493-500
|Abstract »|Full Text »|PDF »
SMAC Mimetics Sensitize Nonsteroidal Anti-inflammatory Drug Induced Apoptosis by Promoting Caspase-3 Mediated Cytochrome c Release.
A. Bank, P. Wang, C. Du, J. Yu, and L. Zhang (2008)
Cancer Res.
68, 276-284
|Abstract »|Full Text »|PDF »
Chemosensitization of head and neck cancer cells by PUMA.
Q. Sun, T. Sakaida, W. Yue, S. M. Gollin, and J. Yu (2007)
Mol. Cancer Ther.
6, 3180-3188
|Abstract »|Full Text »|PDF »
A Dimeric Smac/Diablo Peptide Directly Relieves Caspase-3 Inhibition by XIAP: DYNAMIC AND COOPERATIVE REGULATION OF XIAP BY SMAC/DIABLO.
Z. Gao, Y. Tian, J. Wang, Q. Yin, H. Wu, Y.-M. Li, and X. Jiang (2007)
J. Biol. Chem.
282, 30718-30727
|Abstract »|Full Text »|PDF »
The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer.
MCL-1 as a Buffer for Proapoptotic BCL-2 Family Members during TRAIL-induced Apoptosis: A MECHANISTIC BASIS FOR SORAFENIB (BAY 43-9006)-INDUCED TRAIL SENSITIZATION.
X. W. Meng, S.-H. Lee, H. Dai, D. Loegering, C. Yu, K. Flatten, P. Schneider, N. T. Dai, S. K. Kumar, B. D. Smith, et al. (2007)
J. Biol. Chem.
282, 29831-29846
|Abstract »|Full Text »|PDF »
Lipid Rafts and Nonrafts Mediate Tumor Necrosis Factor Related Apoptosis-Inducing Ligand Induced Apoptotic and Nonapoptotic Signals in Non Small Cell Lung Carcinoma Cells.
J. H. Song, M. C.L. Tse, A. Bellail, S. Phuphanich, F. Khuri, N. M. Kneteman, and C. Hao (2007)
Cancer Res.
67, 6946-6955
|Abstract »|Full Text »|PDF »
Modifications enhance the apoptosis-inducing activity of FADD.
Taming a Protein-Protein Interaction: The Design and Synthesis of IAP Antagonists.
C. S. Straub, S. K. Sharma, and L. S. Zawel (2007)
Am. Assoc. Cancer Res. Educ. Book
2007, 117-122
|Full Text »|PDF »
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).
D. Chauhan, P. Neri, M. Velankar, K. Podar, T. Hideshima, M. Fulciniti, P. Tassone, N. Raje, C. Mitsiades, N. Mitsiades, et al. (2007)
Blood
109, 1220-1227
|Abstract »|Full Text »|PDF »
Bid-Independent Mitochondrial Activation in Tumor Necrosis Factor Alpha-Induced Apoptosis and Liver Injury.
X. Chen, W.-X. Ding, H.-M. Ni, W. Gao, Y.-H. Shi, A. A. Gambotto, J. Fan, A. A. Beg, and X.-M. Yin (2007)
Mol. Cell. Biol.
27, 541-553
|Abstract »|Full Text »|PDF »
Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin.
W. S. Tsai, W.-S. Yeow, A. Chua, R. M. Reddy, D. M. Nguyen, D. S. Schrump, and D. M. Nguyen (2006)
Mol. Cancer Ther.
5, 2977-2990
|Abstract »|Full Text »|PDF »
Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor.
W. Xu, L. Ngo, G. Perez, M. Dokmanovic, and P. A. Marks (2006)
PNAS
103, 15540-15545
|Abstract »|Full Text »|PDF »
Inducible Resistance of Tumor Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 2-Mediated Apoptosis by Generation of a Blockade at the Death Domain Function..
Y. Li, H. Wang, Z. Wang, S. Makhija, D. Buchsbaum, A. LoBuglio, R. Kimberly, and T. Zhou (2006)
Cancer Res.
66, 8520-8528
|Abstract »|Full Text »|PDF »
Preclinical Characterization of AEG35156/GEM 640, a Second-Generation Antisense Oligonucleotide Targeting X-Linked Inhibitor of Apoptosis.
E. C. LaCasse, G. G. Cherton-Horvat, K. E. Hewitt, L. J. Jerome, S. J. Morris, E. R. Kandimalla, D. Yu, H. Wang, W. Wang, R. Zhang, et al. (2006)
Clin. Cancer Res.
12, 5231-5241
|Abstract »|Full Text »|PDF »
Newcastle Disease Virus Exerts Oncolysis by both Intrinsic and Extrinsic Caspase-Dependent Pathways of Cell Death..
S. Elankumaran, D. Rockemann, and S. K. Samal (2006)
J. Virol.
80, 7522-7534
|Abstract »|Full Text »|PDF »
X-linked inhibitor of apoptosis antagonism: strategies in cancer treatment..
H. H. Cheung, E. C. LaCasse, and R. G. Korneluk (2006)
Clin. Cancer Res.
12, 3238-3242
|Full Text »|PDF »
Autophagy occurs upstream or parallel to the apoptosome during histolytic cell death.
F. Akdemir, R. Farkas, P. Chen, G. Juhasz, L. Medved'ova, M. Sass, L. Wang, X. Wang, S. Chittaranjan, S. M. Gorski, et al. (2006)
Development
133, 1457-1465
|Abstract »|Full Text »|PDF »
Monitoring 14-3-3 Protein Interactions with a Homogeneous Fluorescence Polarization Assay.
Y. Du, S. C. Masters, F. R. Khuri, and H. Fu (2006)
J Biomol Screen
11, 269-276
|Abstract »|PDF »
Chemotherapeutic approaches for targeting cell death pathways..
Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Destruction.
A. Eramo, R. Pallini, F. Lotti, G. Sette, M. Patti, M. Bartucci, L. Ricci-Vitiani, M. Signore, G. Stassi, L. M. Larocca, et al. (2005)
Cancer Res.
65, 11469-11477
|Abstract »|Full Text »|PDF »
Enhancement of Sensitivity to Tumor Necrosis Factor {alpha} in Non-Small Cell Lung Cancer Cells with Acquired Resistance to Gefitinib.
K. Ando, T. Ohmori, F. Inoue, T. Kadofuku, T. Hosaka, H. Ishida, T. Shirai, K. Okuda, T. Hirose, N. Horichi, et al. (2005)
Clin. Cancer Res.
11, 8872-8879
|Abstract »|Full Text »|PDF »
ras Oncogene Triggers Up-regulation of cIAP2 and XIAP in Intestinal Epithelial Cells: EPIDERMAL GROWTH FACTOR RECEPTOR-DEPENDENT AND -INDEPENDENT MECHANISMS OF ras-INDUCED TRANSFORMATION.
Z. Liu, H. Li, M. Derouet, J. Filmus, E. C. LaCasse, R. G. Korneluk, R. S. Kerbel, and K. V. Rosen (2005)
J. Biol. Chem.
280, 37383-37392
|Abstract »|Full Text »|PDF »
Silencing of Human Phosphatidylethanolamine-Binding Protein 4 Sensitizes Breast Cancer Cells to Tumor Necrosis Factor-{alpha}-Induced Apoptosis and Cell Growth Arrest.
X. Wang, N. Li, H. Li, B. Liu, J. Qiu, T. Chen, and X. Cao (2005)
Clin. Cancer Res.
11, 7545-7553
|Abstract »|Full Text »|PDF »
Apoptosis-based therapies for hematologic malignancies.
Synergistic enhancement of TRAIL- and tumor necrosis factor {alpha}-induced cell death by a phenoxazine derivative.
K. Hara, M. Okamoto, T. Aki, H. Yagita, H. Tanaka, Y. Mizukami, H. Nakamura, A. Tomoda, N. Hamasaki, and D. Kang (2005)
Mol. Cancer Ther.
4, 1121-1127
|Abstract »|Full Text »|PDF »
New Approaches and Therapeutics Targeting Apoptosis in Disease.
SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells.
M. Kohli, J. Yu, C. Seaman, A. Bardelli, K. W. Kinzler, B. Vogelstein, C. Lengauer, and L. Zhang (2004)
PNAS
101, 16897-16902
|Abstract »|Full Text »|PDF »